Plasminogen Activator Inhibitor-1 Antagonist TM5484 Attenuates Demyelination and Axonal Degeneration in a Mice Model of Multiple Sclerosis

• Nicolas Pelisch ,

  * E-mail: n.pelisch@med.tohoku.ac.jp

  Affiliation Department of Molecular Medicine and Therapy, United Centers for Advanced Research and Translational Medicine, Tohoku University Graduate School of Medicine, Sendai, Miyagi, Japan

  ⨯
• Takashi Dan,

  Affiliation Department of Molecular Medicine and Therapy, United Centers for Advanced Research and Translational Medicine, Tohoku University Graduate School of Medicine, Sendai, Miyagi, Japan

  ⨯
• Atsuhiko Ichimura,

  Affiliation Department of Molecular Medicine and Therapy, United Centers for Advanced Research and Translational Medicine, Tohoku University Graduate School of Medicine, Sendai, Miyagi, Japan

  ⨯
• Hiroki Sekiguchi,

  Affiliation Department of Molecular Medicine and Therapy, United Centers for Advanced Research and Translational Medicine, Tohoku University Graduate School of Medicine, Sendai, Miyagi, Japan

  ⨯
• Douglas E. Vaughan,

  Affiliation Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois, United States of America

  ⨯
• Charles van Ypersele de Strihou,

  Affiliation Service de Nephrologie, Cliniques Universitaires Saint Luc, Brussels, Belgium

  ⨯
• Toshio Miyata

  Affiliation Department of Molecular Medicine and Therapy, United Centers for Advanced Research and Translational Medicine, Tohoku University Graduate School of Medicine, Sendai, Miyagi, Japan

  ⨯